Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD | B Stock News

Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD | B Stock News

StockTitan

Mar 16, 2026 at 10:40 PM

Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD | B Stock News

Cereno Scientific Receives Approval to Initiate FDA-aligned Phase I Pharmacokinetic Study of CS014 Supporting Phase II Development in PH-ILD | B Stock News

Login to unlock155characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

CERo Therapeutics

USCERO

-9.91%

VanEck Biotech ETF

USBBH

Invesco Biotechnology & Genome ETF

USPBE

LongbridgeAI